J7401 HCPCS code: Mometasone furoate sinus implant, 10 micrograms
J7401 is the HCPCS Level II code for mometasone furoate sinus implant, 10 micrograms. CMS terminated J7401 on 2021-03-31; do not bill it for later dates of service. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2019-10-01 |
| Last action effective | 2021-04-01 |
| Terminated | 2021-03-31 |
What changed for J7401
- 2019-10-01: J7401 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7401?
J7401 is the HCPCS Level II code for mometasone furoate sinus implant, 10 micrograms. Short descriptor: "Mometasone furoate sinus imp".
Does Medicare cover J7401?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related J74 codes
- J7402 — Mometasone furoate sinus implant, (sinuva), 10 micrograms
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7401
- Watch J7401 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7401
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.